OCUL vs AAPL: Which is Better to Buy in 2026?

Side-by-side fundamental comparison based on AI analysis of SEC filings

AI Verdict

AAPL has stronger fundamentals based on our AI analysis.

OCUL
OCULAR THERAPEUTIX, INC
SELL
72%
Confidence
VS
AAPL
Apple Inc.
BUY
87%
Confidence

OCUL vs AAPL Fundamental Comparison

Metric OCUL AAPL
Revenue $52.0M $143.8B
Net Income $-265.9M $42.1B
Net Margin -511.9% 29.3%
ROE -40.6% 47.7%
ROA -32.9% 11.1%
Current Ratio 15.39x 0.97x
Debt/Equity 0.04x 1.00x
EPS $-1.42 $2.84

Green = Better metric | Red = Weaker metric

View Full OCUL Analysis →
View Full AAPL Analysis →
Browse Sectors: Technology Healthcare Finance Energy Consumer Industrial
Stock Lists: Strong Buy Undervalued Growth Dividend

You Might Also Compare

OCUL vs MSFT AAPL vs GOOGL OCUL vs AMZN AAPL vs NVDA

OCUL vs AAPL: Frequently Asked Questions

Is OCUL or AAPL a better buy in 2026?

Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. OCUL is rated SELL (72% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.

How does OCUL compare to AAPL fundamentally?

OCULAR THERAPEUTIX, INC has ROE of -40.6% vs Apple Inc.'s 47.7%. Net margins are -511.9% vs 29.3% respectively.

Which stock pays higher dividends, OCUL or AAPL?

OCUL has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.

Should I invest in OCUL or AAPL for long term?

For long-term investing, consider that OCUL has SELL rating with 72% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.

What do the AI models say about OCUL vs AAPL?

Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For OCUL vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.